| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Lineberger Comprehensive Cancer Center,
Department of Microbiology and Immunology, and
Curriculum in Oral Biology, School of Dentistry, University of North Carolina, Chapel Hill, NC 27599
The presence of the class II transactivator (CIITA) activates the transcription of all MHC class II genes. Previously, we reported that deletion of a carboxyl-terminal nuclear localization signal (NLS) results in the cytoplasmic localization of CIITA and one form of the type II bare lymphocyte syndrome. However, further sequential carboxyl-terminal deletions of CIITA resulted in mutant forms of the protein that localized predominantly to the nucleus, suggesting the presence of one or more additional NLS in the remaining sequence. We identified a 10-aa motif at residues 405–414 of CIITA that contains strong residue similarity to the classical SV40 NLS. Deletion of this region results in cytoplasmic localization of CIITA and loss of transactivation activity, both of which can be rescued by replacement with the SV40 NLS. Fusion of this sequence to a heterologous protein results in its nuclear translocation, confirming the identification of a NLS. In addition to nuclear localization sequences, CIITA is also controlled by nuclear export. Leptomycin B, an inhibitor of export, blocked the nuclear to cytoplasmic translocation of CIITA; however, leptomycin did not alter the localization of the NLS mutant, indicating that this region mediates only the rate of import and does not affect CIITA export. Several candidate nuclear export sequences were also found in CIITA and one affected the export of a heterologous protein. In summary, we have demonstrated that CIITA localization is balanced between the cytoplasm and nucleus due to the presence of NLS and nuclear export signal sequences in the CIITA protein.
This article has been cited by other articles:
|
|
 |
|
  L. N. Voong, A. R. Slater, S. Kratovac, and D. E. Cressman Mitogen-activated Protein Kinase ERK1/2 Regulates the Class II Transactivator J. Biol. Chem., April 4, 2008; 283(14): 9031 - 9039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Tang, K. A. Trzaska, S. V. Smirnov, S. V. Kotenko, S. K. Schwander, J. J. Ellner, and P. Rameshwar Down-Regulation of MHC II in Mesenchymal Stem Cells at High IFN-{gamma} Can Be Partly Explained by Cytoplasmic Retention of CIITA J. Immunol., February 1, 2008; 180(3): 1826 - 1833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Herrmann, R. S. Agrawal, S. F. Connolly, R. L. McCaffrey, J. Schlomann, and D. J. Kusner MHC Class II levels and intracellular localization in human dendritic cells are regulated by calmodulin kinase II J. Leukoc. Biol., September 1, 2007; 82(3): 686 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Tosi, E. Pilotti, L. Mortara, A. D. L. Barbaro, C. Casoli, and R. S. Accolla Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y PNAS, August 22, 2006; 103(34): 12861 - 12866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Zika, L. Fauquier, L. Vandel, and J. P.-Y. Ting Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-{gamma}-inducible MHC-II gene expression PNAS, November 8, 2005; 102(45): 16321 - 16326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Conti, B. K. Davis, J. Zhang, W. O'Connor Jr., K. L. Williams, and J. P.-Y. Ting CATERPILLER 16.2 (CLR16.2), a Novel NBD/LRR Family Member That Negatively Regulates T Cell Function J. Biol. Chem., May 6, 2005; 280(18): 18375 - 18385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Greer, J. A. Harton, M. W. Linhoff, C. A. Janczak, J. P.-Y. Ting, and D. E. Cressman Serine Residues 286, 288, and 293 within the CIITA: A Mechanism for Down-Regulating CIITA Activity through Phosphorylation J. Immunol., July 1, 2004; 173(1): 376 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Camacho-Carvajal, S. Klingler, F. Schnappauf, S. B. Hake, and V. Steimle Importance of class II transactivator leucine-rich repeats for dominant-negative function and nucleo-cytoplasmic transport Int. Immunol., January 1, 2004; 16(1): 65 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Zika, S. F. Greer, X.-S. Zhu, and J. P.-Y. Ting Histone Deacetylase 1/mSin3A Disrupts Gamma Interferon-Induced CIITA Function and Major Histocompatibility Complex Class II Enhanceosome Formation Mol. Cell. Biol., May 1, 2003; 23(9): 3091 - 3102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Raval, J. D. Weissman, T. K. Howcroft, and D. S. Singer The GTP-Binding Domain of Class II Transactivator Regulates Its Nuclear Export J. Immunol., January 15, 2003; 170(2): 922 - 930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Barbieri, V. Deffrennes, T. Prod'homme, J. Vedrenne, F. Baton, C. Cortes, A. Fischer, M.-R. Bono, B. Lisowska-Grospierre, D. Charron, et al. Isoforms of the class II transactivator protein Int. Immunol., August 1, 2002; 14(8): 839 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Pai, D. Askew, W. H. Boom, and C. V. Harding Regulation of Class II MHC Expression in APCs: Roles of Types I, III, and IV Class II Transactivator J. Immunol., August 1, 2002; 169(3): 1326 - 1333. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
